BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36074515)

  • 1. Supplement Article: The Role of Epidermal Barrier Dysfunction and Cutaneous Microbiome Dysbiosis in the Pathogenesis and Management of Acne Vulgaris and Rosacea.
    Marson J; Bhatia N; Graber E; Harper J; Lio P; Tlougan B; Nussbaum D; Baldwin H
    J Drugs Dermatol; 2022 Sep; 21(9):SF3502915-SF35029114. PubMed ID: 36074515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens.
    Baldwin H; Alexis AF; Andriessen A; Berson DS; Farris P; Harper J; Lain E; Marchbein S; Stein Gold L; Tan J
    J Drugs Dermatol; 2021 Apr; 20(4):384-392. PubMed ID: 33852244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens.
    Baldwin H; Alexis A; Andriessen A; Berson D; Harper J; Lain E; Marchbein S; Stein Gold L
    J Drugs Dermatol; 2022 Sep; 21(9):SF3595563-SF35955610. PubMed ID: 36074516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and Maintenance of Cutaneous Rosacea in Latino Skin Types With Prescription Medications and Non-Prescription Cleansers and Moisturizers as Adjuncts: A Review.
    Gonzalez C; Andriessen A; Antelo D; Cestari S; McKeever C; Valencia Hernandez AL
    J Drugs Dermatol; 2022 Oct; 21(10):1111-1118. PubMed ID: 36219059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acne microbiome: From phyla to phylotypes.
    Dreno B; Dekio I; Baldwin H; Demessant AL; Dagnelie MA; Khammari A; Corvec S
    J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):657-664. PubMed ID: 37777343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing the Right Partner: Complementing Prescription Acne Medication With Over-the-Counter Cleansers and Moisturizers.
    Lain E; Andriessen AE
    J Drugs Dermatol; 2020 Nov; 19(11):1069-1075. PubMed ID: 33196748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supplement Article: Dysbiosis, (Barrier) Dysfunction, and Dermatoses: A Chicken-and-Egg Dilemma.
    Marson J; Baldwin H
    J Drugs Dermatol; 2022 Sep; 21(9):SF3502913-SF3502914. PubMed ID: 36074514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review of the Challenges and Nuances in Treating Rosacea in Asian Skin Types Using Cleansers and Moisturizers as Adjuncts.
    Kulthanan K; Andriessen A; Jiang X; Lee CH; Zhang CF
    J Drugs Dermatol; 2023 Jan; 22(1):45-53. PubMed ID: 36607763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Skin Microbiome: A New Actor in Inflammatory Acne.
    Dréno B; Dagnelie MA; Khammari A; Corvec S
    Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acne vulgaris and rosacea: evaluation and management.
    Webster GF
    Clin Cornerstone; 2001; 4(1):15-22. PubMed ID: 12739318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert consensus on holistic skin care routine: Focus on acne, rosacea, atopic dermatitis, and sensitive skin syndrome.
    Goh CL; Wu Y; Welsh B; Abad-Casintahan MF; Tseng CJ; Sharad J; Jung S; Rojanamatin J; Sitohang IBS; Chan HNK
    J Cosmet Dermatol; 2023 Jan; 22(1):45-54. PubMed ID: 36409588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the skin microbiota in acne and rosacea.
    Thompson KG; Rainer BM; Antonescu C; Florea L; Mongodin EF; Kang S; Chien AL
    Exp Dermatol; 2021 Oct; 30(10):1375-1380. PubMed ID: 32278334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical modalities for treating acne and rosacea.
    Jalian HR; Levin Y; Wanner M
    Semin Cutan Med Surg; 2016 Jun; 35(2):96-102. PubMed ID: 27416315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Rosacea Outcomes in Skin of Color Patients: A Review on the Nuances in the Treatment and the Use of Cleansers and Moisturizers.
    Alexis A; Woolery-Lloyd H; Andriessen A; Desai S; Han G; Rodriguez D
    J Drugs Dermatol; 2022 Jun; 21(6):574-580. PubMed ID: 35674765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal Barrier Integrity is Associated with Both Skin Microbiome Diversity and Composition in Patients with Acne Vulgaris.
    Zhou L; Liu X; Li X; He X; Xiong X; Lai J
    Clin Cosmet Investig Dermatol; 2022; 15():2065-2075. PubMed ID: 36196252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Many Faces of Pediatric Acne: How to Tailor Nonprescription Acne Treatment and Skincare Using Cleansers and Moisturizers.
    Schachner L; Andriessen A; Benjamin L; Dones M; Kircik L; Pinera-Llano A; Keller L; Hebert A
    J Drugs Dermatol; 2022 Jun; 21(6):602-612. PubMed ID: 35674768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship of Proper Skin Cleansing to Pathophysiology, Clinical Benefits, and the Concomitant Use of Prescription Topical Therapies in Patients with Acne Vulgaris.
    Levin J
    Dermatol Clin; 2016 Apr; 34(2):133-45. PubMed ID: 27015773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin and gut microbiota dysbiosis in autoimmune and inflammatory skin diseases.
    Šuler Baglama Š; Trčko K
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Sep; 31(3):105-109. PubMed ID: 36149040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and epidermal barrier function of papulopustular rosacea: A comparison study with acne vulgaris.
    Zhou M; Xie H; Cheng L; Li J
    Pak J Med Sci; 2016; 32(6):1344-1348. PubMed ID: 28083023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights Into Systemic Drivers of Inflammation and Their Contributions to the Pathophysiology of Acne.
    Del Rosso J; Farris PK; Harper J; Baldwin H; Hazan A; Raymond I
    J Drugs Dermatol; 2024 Feb; 23(2):90-96. PubMed ID: 38306144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.